Margaret Tooth Sells 4,000 Shares of Trupanion, Inc. (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $37.17, for a total value of $148,680.00. Following the transaction, the chief executive officer now owns 118,784 shares in the company, valued at $4,415,201.28. This represents a 3.26 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Margaret Tooth also recently made the following trade(s):

• On Tuesday, March 4th, Margaret Tooth sold 2,294 shares of Trupanion stock. The shares were sold at an average price of $31.39, for a total value of $72,008.66.

Trupanion Stock Performance

Shares of TRUP opened at $37.80 on Wednesday. The stock has a market capitalization of $1.61 billion, a P/E ratio of -164.35, a P/E/G ratio of 6.02 and a beta of 1.70. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. Trupanion, Inc. has a 1 year low of $19.69 and a 1 year high of $57.90. The company’s fifty day moving average is $41.42 and its two-hundred day moving average is $46.67.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The firm had revenue of $337.31 million for the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. On average, sell-side analysts predict that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts recently commented on TRUP shares. Stifel Nicolaus reduced their price target on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research report on Thursday, February 20th. Piper Sandler dropped their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $46.60.

Hedge Funds Weigh In On Trupanion

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. FMR LLC boosted its stake in shares of Trupanion by 55,963.7% in the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after buying an additional 1,170,202 shares in the last quarter. Balyasny Asset Management L.P. boosted its position in shares of Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock worth $40,548,000 after purchasing an additional 661,559 shares in the last quarter. BNP Paribas Financial Markets grew its stake in shares of Trupanion by 170.7% during the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider’s stock worth $16,248,000 after purchasing an additional 212,545 shares during the period. Freestone Grove Partners LP acquired a new stake in shares of Trupanion in the fourth quarter valued at about $7,776,000. Finally, Baillie Gifford & Co. boosted its holdings in Trupanion by 26.6% during the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after buying an additional 147,341 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.